• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMU 0.00% 5.5¢

IMUGENE LIMITED

Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing... Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs. More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IMU
Why IMU is a multi multi bagger
18:47 25K 12M
18:47 Last post  Kombumerri Comments Created with Sketch.  25K  Views Created with Sketch.  12M 
IMU
IMUGENE CHART. TA only
18:34 33K 16M
18:34 Last post  slick Comments Created with Sketch.  33K  Views Created with Sketch.  16M 
IMU
Media Thread
26/07/24 14K 7.0M
26/07/24 Last post  wednesdayschild Comments Created with Sketch.  14K  Views Created with Sketch.  7.0M 
IMU
Why doesn't this company do a share consolidation?
26/07/24 39 14K
26/07/24 Last post  jwt Comments Created with Sketch.  39  Views Created with Sketch.  14K 
IMU
Stop the rort
26/07/24 19 7.1K
26/07/24 Last post  tak1 Comments Created with Sketch.  19  Views Created with Sketch.  7.1K 
IMU
Mast trial protocol update
20/07/24 0 1.0K
20/07/24 Last post  reon1 Comments Created with Sketch.  0  Views Created with Sketch.  1.0K 
IMU 17/07/24 182 85K
17/07/24 Last post  DDD24 Comments Created with Sketch.  182  Views Created with Sketch.  85K 
IMU 17/07/24 159 75K
17/07/24 Last post  GMT2 Comments Created with Sketch.  159  Views Created with Sketch.  75K 

See All Discussions arrow Created with Sketch.

Timeline

Notification of cessation of securities - IMU
12 Jul 17:28
 
Notification regarding unquoted securities - IMU
12 Jul 17:19
 
First patient dosed in Phase 1 bile tract cancer trial
10 Jul 09:20
 
Change of Director's Interest Notice x6
08 Jul 16:50
 
Application for quotation of securities - IMU
08 Jul 11:20
 
Imugene Corporate Presentation
04 Jul 15:44
 
View More arrow Created with Sketch.
(20min delay)
Last
5.5¢
Change
0.000(0.00%)
Mkt cap ! $404.2M
Open High Low Value Volume
5.6¢ 5.7¢ 5.5¢ $379.9K 6.840M

Buyers (Bids)

No. Vol. Price($)
15 1581916 5.5¢
 

Sellers (Offers)

Price($) Vol. No.
5.6¢ 680013 6
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
Last
5.6¢
  Change
0.000 ( 2.59 %)
Open High Low Volume
5.5¢ 5.7¢ 5.5¢ 5741589
Last updated 15.59pm 26/07/2024 ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.